Evidence map›Paper›PMID 26629154›Full record

ArticleInternational journal of clinical and experimental medicine2015

Comparison of anti-reflux mechanism between Double-J-Stent and standart Double-J-Stent use for risk of BK nephropathy and urinary tract Infection in kidney transplantation.

Nurettin Ay, Mehmet Veysi Bahadır, Melih Anıl, Vahhac Alp, Şafak Kaya, Utkan Sevük, Mesut Gül, Ramazan Danış

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Early double J stent removal in renal transplant patients to prevent urinary tract infection - systematic review and meta-analysis of randomized controlled trials.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nurettin AyDiyarbakir Education and Research Hospital, Transplantation Center Diyarbakir, Turkey.
Mehmet Veysi BahadırDepartment of General Surgery, Dicle University Education and Research Hospital Diyarbakir, Turkey.
Melih AnılDepartment of Nephrology, Diyarbakır Gazi Yaşargil Education and Research Hospital Diyarbakır, Turkey.
Vahhac AlpDiyarbakir Education and Research Hospital, Transplantation Center Diyarbakir, Turkey.
Şafak KayaDepartment of Infectious Disease, Diyarbakır Gazi Yaşargil Training and Research Hospital Diyarbakır, Turkey.
Utkan SevükDepartment of Cardiovascular Surgery, Diyarbakır Gazi Yaşargil Education and Research Hospital Diyarbakır, Turkey.
Mesut GülDepartment of General Surgery, Dicle University Education and Research Hospital Diyarbakir, Turkey.
Ramazan DanışDepartment of Nephrology, Diyarbakır Gazi Yaşargil Education and Research Hospital Diyarbakır, Turkey.
Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi · TRDicle University · TRDiyarbakır Askeri Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThere are studies that show that double J stenting (DJS) increase BK nephropathy (BKN) 4 fold. DJS may cause vesicoureteral reflux (VUR) with normal bladder contraction. The aim of this study is to comparison risk of BKN, urinary tract infections (UTI) and postoperative urologic complications with the use DJS with anti-reflux device (ARD-DJS) and standart double J stent (St-DJS). Matherial and methods: Ninety patients (male/female: 50/40) that had undergone kidney transplantations in Diyarbakır Training and Research Hospital and Dicle University, Faculty of Medicine Hospital between January 2012 and April 2015 were enrolled in the study. Demographic data, immunosuppression protocols, presence of rejection, graft loss, postoperative urologic complications, UTI, plasma BK levels of the patients were evaluated retrospectively.

resultsMedian and IQR follow up time for ARD-DJS and St-DJS patients were 14 (12-18) months and 25 (16-30) months respectively. Five cases (5.5%) had BK viremia (P=0.025). All 5 cases with BK viremia were St-DJS users.

conclusionAs a result for postoperative UTI and postoperative urinary complication risk there were no statistically significant difference between ARD-DJS use and St-DJS use during ureteral anastomosis. BKN univariate analysis were significantly less than those st-DJS used. Risc factors were evaluated. But results were not statistically significant in the logistic regression analysis. We think that to demonstrate this benefit, we need randomized controlled studies with more patients and longer follow up.

Indexed as

anti-reflux deviceBK nephropathyDouble J stenting

Identifiers

PMID26629154
PMCPMC4659042
OpenAlexW2415616765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.